Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

In a report released today, Krish Sankar from TD Cowen reiterated a Buy rating on Silvaco Group, Inc. (SVCO – Research Report), with a price ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...

TD Cowen analyst Oliver Chen maintained a Hold rating on Nordstrom (JWN – Research Report) today and set a price target of $25.00. The ...

Calumet downgraded at TD Cowen, saying the market has more fully accounted for near-term risks both for the Montana Renewable ...

MYT Netherlands (NYSE:MYTE) shares rose more than 5% intra-day today after TD Cowen analysts upgraded the stock from Hold to ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Merck’s stock has fallen 7.27% year-to-date, raising investor concerns. Despite a 1.84% gain on Friday, the stock remains ...